Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-30 @ 2:54 AM
Study NCT ID:
NCT07492394
Status:
RECRUITING
Last Update Posted:
2026-03-25
First Post:
2025-12-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer
Sponsor:
Hebei Medical University Fourth Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
OBU-BC-II-278
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |